MYSTIC, CT, United States of America

Advaita Panchagnula

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Pfizer Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Advaita Panchagnula. Retrieved from https://idiyas.com/inventor/advaita-panchagnula

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 19.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Advaita Panchagnula: Innovator in Pharmaceutical Research

Introduction

Advaita Panchagnula is an inventor based in Mystic, CT (US). He is known for his contributions to pharmaceutical research, particularly in the field of diabetes and obesity treatment. Although he currently holds no granted patents, his innovative work is reflected in his latest patent applications.

Latest Patent Applications

Advaita Panchagnula has filed several notable patent applications. One of his latest applications is titled "GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF." This application describes compounds of Formula I and their pharmaceutically acceptable salts, detailing their use as GIPR antagonists. These compounds aim to treat or prevent conditions such as obesity, weight gain, and type 2 diabetes mellitus (T2DM). Another significant application is for "COMPOUNDS FOR THE ACTIVATION OF AMPK," which also describes compounds of Formula I.

Conclusion

Advaita Panchagnula's work in pharmaceutical research showcases his commitment to developing innovative solutions for pressing health issues. His latest patent applications highlight his potential impact in the field, particularly in addressing obesity and diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…